Skip to content
healthcare.dev

Nicotine Polacrilex

NDC 45802-089, Nicotine Polacrilex, lozenge, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-089
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA203690
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-089 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NICOTINE2 mg/1

Pharmacologic classes

Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]

Package NDCNDC-11Package
45802-089-02458020089023 CONTAINER in 1 CARTON (45802-089-02) / 27 LOZENGE in 1 CONTAINER (45802-089-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 45802008902

    GET /v1/drugs/nadac/45802008902

Use it

Look up 45802-089 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-089 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-089. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.